Drug fends off kidney cancer progressionDate: Fri, May 16
Published in:
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on othe...
[more]Researchers expand natural killer cells in cord blood to fight leukemiaDate: Fri, May 16
Published in:
Researchers from The University of Texas M. D. Anderson Cancer Center have found a therapy that effectively kills human leukemia cells in mice using natural killer cells from umbilical cord blood....
[more]Bone drug could help prevent the spread of breast cancerDate: Fri, May 16
Published in:
Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to research at Washington University School of Medicine in St. Louis. ...
[more]New drug combination brings 1-2 punch against acute leukemiaDate: Fri, May 16
Published in:
Researchers at the University of Texas M. D. Anderson Cancer Center have discovered a drug combination that kills leukemia cells by shutting down their energy source and hastening cell starvation....
[more]Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapyDate: Fri, May 16
Published in:
Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II...
[more]Novel enzyme inhibitor paves way for new cancer drugDate: Fri, May 16
Published in:
Wistar Institute scientists have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key role in cancer development. Based on studies in human melanoma cells, the research paves the way for developing new ways...
[more]